Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Syneron Reports Third Quarter 2009 Financial Results
Syneron Medical Ltd. Approves an Amendment to Its Rights Agreement
Candela Announces Results for the First Fiscal Quarter 2010
Syneron Medical Ltd. And Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company
Real Housewives of Orange County Star Gretchen Rossi Reveals Next and Best in Beauty Live from the World's Most Exclusive Aesthetics Conference
Syneron Reports Second Quarter 2009 Results
Syneron Medical to Announce Second Quarter 2009 Financial Results on August 13th, 2009
Syneron Medical to Present at the Gabelli & Company Small Cap Healthcare Conference and the Needham Growth Conference
Syneron to Launch Industry-First Treatment Modality, New Product for Procedures Leading to Body Contouring and Physician-Focused Initiative at THE Aesthetics Show
Gabelli & Company, Inc.’s Healthcare Symposium
Syneron Reports First Quarter 2009 Results
triniti(TM) Skin Treatment to be Featured in Keeping Up with The Kardashians Episode
Matrix RF(TM) Live Treatment to Air on April 23 Episode of "THE Doctors"
Syneron Medical Moves Forward in Shift Toward Recurring Revenue Models in Response to New Market Environment
Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot
Syneron Dental Announces European OEM Agreement
Syneron(TM) Unveils New eMatrix(TM) Clinical Data on Fractional Treatments for Darker Skin Types at American Academy of Dermatology Annual Meeting
Syneron(TM) Partners With the American Academy of Cosmetic Physicians (AAOCP) to Train LipoLite(TM) and Laser LipoSculpture Physicians
Syneron Reports Fourth Quarter and Full Year 2008 Results
Syneron Medical Announces Management Change to Support Strengthening of Syneron's Leadership Position in a Challenging Professional Aesthetic Market
Syneron(TM) Unveils Elegant, Portable eMatrix(TM) Skin Resurfacing System
Syneron Medical Announces the Establishment of Syneron China
Syneron Medical Adopts Shareholder Rights Plan
Syneron Reports Third Quarter 2008 Revenues of $28.5 Million
Syneron(TM) Acquires San Diego-Based Inlight Corp.
Syneron Medical to Present at Oppenheimer Healthcare Conference and Barclays Capital Small and Mid-Cap Healthcare Conference
Syneron Issues Preliminary Results for the Third Quarter of 2008 and Schedules Quarterly Earnings Conference Call
Syneron Medical to Present at Maxim Group Growth Conference
Syneron(TM) Receives FDA Clearance for Versatile Matrix RF(TM) Fractional Ablative Applicator
Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
Syneron Medical to Present at UBS Global Life Sciences Conference
Celebrity Moms' Post-Baby Body Triggers Jealousy, Skepticism in U.S. Moms
/ CORRECTION - Syneron Medical to Present at Thomas Weisel Healthcare Conference
Syneron Medical to Present at Thomas Weisel Healthcare Conference
Syneron Reports Record Second Quarter 2008 Revenues of $38.2 Million and Net Profit of $11.0 Million
Syneron Launches Aesthetic Industry's First Physician Subscription Program for Its LipoLite(TM) Laser-Assisted Lipolysis Device
Syneron Medical to Announce Second Quarter 2008 Financial Results on August 14, 2008
Wall Street Media Presents Exclusive Video Highlights from the Collins Stewart Conference and the T. Boone Pickens Press Conference
Syneron Medical to Present at Collins Stewart Growth Conference
Syneron Signs Multi-Year Exclusive Equipment Provider Agreement with Sono Bello Contouring Centers to Offer LipoLite(TM) and VelaShape(TM)
Syneron Reports First Quarter 2008 Revenues of $34.1 Million and Net Profit of $8.3 Million - Jun 1 2008 8:57PM
THE Aesthetic Show Advances $34 Billion Market - Jun 1 2008 6:49AM
Syneron Medical to Announce First Quarter 2008 Financial Results on May 14, 2008 - Jun 1 2008 8:57PM
Syneron's LipoLite(TM) Minimally Invasive Laser-Assisted Lypolysis Receives FDA Clearance - Jun 1 2008 8:56PM
Syneron's VelaShape(TM) Proven Effective in Helping Women Achieve 'Before-Baby Body'
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia